Skip to main content
. 2014 Oct 24;9(10):e111144. doi: 10.1371/journal.pone.0111144

Figure 1. Change of antimicrobial susceptibility among E. coli during the 12-year-period.

Figure 1

AMP, ampicillin; AZT, aztreonam; TZP, piperacillin/tazobactam; CFZ, cefazolin; FOX, cefoxitin; CRO, ceftriaxone; FEP, cefepime; QUI, quinolone; TMX, trimethoprim/sulfamethoxazole; AMK, amikacin; GM, gentamicin; TOB, tobramycin; IPM, imipenem. * During the study period, there was a significant decrease in antimicrobial susceptibility on univariate logistic regression analysis (P = 0.040).